ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
ConvaTec Group PLC (PK)

ConvaTec Group PLC (PK) (CNVVY)

12.64
-0.10
(-0.78%)
Cerrado 31 Enero 3:00PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
12.64
Postura de Compra
12.37
Postura de Venta
12.98
Volume Operado de la Acción
7,465
12.38 Rango del Día 12.74
10.77 Rango de 52 semanas 15.40
Capitalización de Mercado [m]
Precio Anterior
12.74
Precio de Apertura
12.58
Última hora de negociación
Volumen financiero
US$ 94,451
Precio Promedio Ponderado
12.6525
Volumen promedio (3 m)
22,200
Acciones en circulación
512,447,390
Rendimiento del Dividendo
1.60%
Ratio Precio/Utilidad
9.79
Beneficio por acción (BPA)
0.25
turnover
2.14B
Beneficio neto
130.3M

Acerca de ConvaTec Group PLC (PK)

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and eco... ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has more than 9,000 employees and does business in more than 100 countries. Mostrar más

Sector
Med, Dental, Hosp Eq-whsl
Industria
Med, Dental, Hosp Eq-whsl
Sitio web
Sede
Reading, Gbr
Fundado
-
ConvaTec Group PLC (PK) is listed in the Med, Dental, Hosp Eq-whsl sector of the OTCMarkets with ticker CNVVY. The last closing price for ConvaTec (PK) was US$12.74. Over the last year, ConvaTec (PK) shares have traded in a share price range of US$ 10.77 to US$ 15.40.

ConvaTec (PK) currently has 512,447,390 shares in issue. The market capitalisation of ConvaTec (PK) is US$6.53 billion. ConvaTec (PK) has a price to earnings ratio (PE ratio) of 9.79.

CNVVY Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.564.635761589412.0812.9311.993378612.45037631DR
41.600514.497939218311.039512.9310.862911211.82107086DR
121.3812.255772646511.2613.410.772220011.73234147DR
260.292.3481781376512.3513.410.771776511.88004978DR
520.8056.8018588931111.83515.410.772443912.56256129DR
1563.1433.05263157899.515.48.691506812.50918294DR
2601.9718.462980318710.6715.46.685928712.29780585DR

CNVVY - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de ConvaTec (PK)?
El precio actual de las acciones de ConvaTec (PK) es US$ 12.64
¿Cuántas acciones de ConvaTec (PK) están en circulación?
ConvaTec (PK) tiene 512,447,390 acciones en circulación
¿Cuál es la capitalización de mercado de ConvaTec (PK)?
La capitalización de mercado de ConvaTec (PK) es USD 6.53B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de ConvaTec (PK)?
ConvaTec (PK) ha negociado en un rango de US$ 10.77 a US$ 15.40 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de ConvaTec (PK)?
El ratio precio/beneficio de ConvaTec (PK) es 9.79
¿Cuál es el ratio de efectivo a ventas de ConvaTec (PK)?
El ratio de efectivo a ventas de ConvaTec (PK) es 0.6
¿Cuál es la moneda de reporte de ConvaTec (PK)?
ConvaTec (PK) presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de ConvaTec (PK)?
El último ingresos anual de ConvaTec (PK) es USD 2.14B
¿Cuál es el último beneficio anual de ConvaTec (PK)?
El último beneficio anual de ConvaTec (PK) es USD 130.3M
¿Cuál es la dirección registrada de ConvaTec (PK)?
La dirección registrada de ConvaTec (PK) es 3 FORBURY PLACE, 23 FORBURY ROAD, READING, RG1 3JH
¿Cuál es la dirección del sitio web de ConvaTec (PK)?
La dirección del sitio web de ConvaTec (PK) es www.convatec.com
¿En qué sector industrial opera ConvaTec (PK)?
ConvaTec (PK) opera en el sector MED, DENTAL, HOSP EQ-WHSL

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
RLLVFRelevium Technologies Inc (CE)
US$ 0.008
(799,900.00%)
8k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
318
CASGCanadian Aerospace Group International (CE)
US$ 0.001
(99,900.00%)
1,000
BLIBQBB Liquidating Inc (CE)
US$ 0.001
(99,900.00%)
204
NTBLQNotable Labs Ltd (CE)
US$ 0.0199
(19,800.00%)
21.97k
ISUNQiSun Inc (CE)
US$ 0.000001
(-99.90%)
200
JFTHJapan Food Tech Holdings Inc (CE)
US$ 0.000001
(-99.50%)
453
JAMNJammin Java Corp (PK)
US$ 0.000001
(-99.00%)
156.25k
INTKIndustrial Nanotech Inc (PK)
US$ 0.000001
(-99.00%)
28.16k
SGMDSugarmade Inc (CE)
US$ 0.000001
(-99.00%)
35.78k
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0002
(100.00%)
228.93M
GMPRGourmet Provisions International Corporation (PK)
US$ 0.000001
(-99.00%)
164.82M
HMBLHUMBL Inc (PK)
US$ 0.0007
(16.67%)
154.01M
THBDThird Bench Inc (PK)
US$ 0.0001
(-33.33%)
133.1M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0028
(-6.67%)
110.11M
USVIHI22 USVIHI22 5 minutos hace
This stock is so last year. Good luck. For me the party is over.
ILST
Top Penny Top Penny 8 minutos hace
Oh yes shorty was wrong, thanks in advance! https://investorshub.advfn.com/uimage/uploads/2016/1/26/hubmx4.gif
PSRU
wagner wagner 10 minutos hace
Right I lost the bet yesterday and would be happier when we will see 3,4,5 bucks...

Material news February can do some magic 
NB
KILLAZILLA KILLAZILLA 13 minutos hace
LOLOLOLOL...where I live, in a rural area of Vegas (on the outskirts), exit right before Mt. Charleston (Lee Canyon), there's Raven's.

Probably one of the most intelligent birds.They resemble a crow, only much larger. I can 100% confirm that they LOVE trash....as I witnessed them pic
RDAR
weedtrader420 weedtrader420 16 minutos hace
BITCOIN 🥴📉🖌️📈🖍️😵‍💫📱 Cross Eyed Mary $140,000 no chart needed
BTCUSD
Bizreader Bizreader 17 minutos hace
"Bite me." See, where this goes is - No you bite me..."#$@." So that's as helpful as the other BS. So obviously, a few people are here are NOT here to help, they're just here to BS themselves. Oh, and they're banding together: so it's here are some documents which I believe firmly are assuring us of
COOP
weedtrader420 weedtrader420 23 minutos hace
BITCOIN BCH $140,000 FEBRUARY TARGET Pink Floyd - MONEY
BTCUSD
Whalatane Whalatane 23 minutos hace
UNCY is supposed to have a commercialization plan presented this Qt .
The Co needs to ramp up but and be ready to roll as soon as OLC is approved . The time line for the TDAPA process ...which is CMS payments beginning is at best 3 mths from approval .
Some recent examples
For
UNCY
Dodger1 Dodger1 23 minutos hace
🥄,could be spoon bending time...go... $AABB

And you naysayers...never mind you....don't need you!

How to Bend a Spoon with Your Mind
YouTube·Skeptic·Jan 5, 2009
AABB
Top Penny Top Penny 23 minutos hace
I'm having a few drinks tonight listening to the devils violinist, I am retired thanks to plays like $PSRU!

https://www.youtube.com/watch?v=vihq22xpl1A
PSRU
wickw50 wickw50 26 minutos hace
$60.00 as of the last filing...
ETEK
Jack_of_All_Trades Jack_of_All_Trades 26 minutos hace
I don't know. You're the f@cking expert. You've devoted your entire pathetic life to this shit.

I'm not even trying to be funny when I say this but the other day I saw a crow eating garbage in a parking lot and I literally thought of you.

RDAR
RDAR
weedtrader420 weedtrader420 30 minutos hace
XRP ETF no more lawsuit ✊😎☝️ WOOHOOOOOO next level up 🪙🪙Hotel California
XRPUSD
MasterBlastr MasterBlastr 35 minutos hace
Meaningless since a true supply/demand dynamic isn't operating.
XRPUSD
alertmeipp alertmeipp 35 minutos hace
The real upside lies in RSV and Enanta’s shift toward becoming an immunology-focused company. Mavyret remains a factor, but the real potential comes from these strategic moves. If executed well, this could be a great setup—we’ll see how it unfolds in the next few quarters.

The waiting
ENTA
Nanotoday Nanotoday 37 minutos hace
I’m not sure why, but I can’t believe you are still a believer. Now, more than ever, you have to admit I was right all along. Or couldn’t you care less?
NNVC
DJPele DJPele 37 minutos hace
Since our patience is starting to grow weary, I figured I would remind everyone of the last 10Q's highlights and what's in store here soon:

Overview

During the first nine months of 2024, the Company continued its progress on multiple fronts, including the following.
NWBO
ace65 ace65 41 minutos hace
$13 volume
ATWT
Money4Nothing-M4N Money4Nothing-M4N 43 minutos hace
CRISPR platforms can result in off-target modifications, unwanted on-target modifications, and genomic rearrangements.

Kim switched to a non-crispr knock in/knock out method. The knock-in knock-out technology allows KBL to work with more complex protein sequences, which are about four
KBLB
Nebuchadnezzar Nebuchadnezzar 43 minutos hace
RITE (Mineral Rite)

https://mineral-rite.com/investor-relations/

https://www.otcmarkets.com/stock/RITE/disclosure

https://x.com/mineralrite/status/1884771921897853390?s=46


read up on this one. if things go as some say, RITE will be
littlejohn littlejohn 44 minutos hace
SMCI has the 33.06 gap down from Friday

01/24 that could fill quick in a price

upturn...44.09 next gap down area...

Around 32.5 was the simple moving price

average when gap down happened...

It happened with 2 selling days, Th
NVDA SMCI
Top Penny Top Penny 44 minutos hace
Share reductions forthcoming!

https://investorshub.advfn.com/uimage/uploads/2017/5/1/fxbnpMoving-picture-money-stacking-up-gif-animation.gif
PSRU
3331 3331 49 minutos hace
Despite showing essentially no effectiveness in a Phase 2 study for LSR - Suzetrigine showed a mean reduction of 2.02 points on the NPRS at week 12, compared to a 1.98 point reduction in the placebo group - the FDA just approved it. Go Figure!

The near-identical reduction to placebo
VRTX
ace65 ace65 49 minutos hace
I too ...but i have been buying down here to try and recoup a little.
Seems to be going up.
DGWR

Su Consulta Reciente

Delayed Upgrade Clock